Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,435 | -1,036 | -386 | N/A | -3,035 |
| Depreciation Amortization | 45 | 62 | 18 | N/A | 157 |
| Accounts receivable | -4 | -50 | -8 | N/A | -51 |
| Accounts payable and accrued liabilities | 1,183 | 854 | 168 | N/A | 1,931 |
| Other Working Capital | 1,134 | 819 | 210 | N/A | 1,973 |
| Other Operating Activity | -1,069 | -804 | -95 | 0 | -1,129 |
| Operating Cash Flow | $-146 | $-156 | $-93 | $N/A | $-154 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 247 | 247 | 137 | N/A | 304 |
| Debt Repayment | -65 | -65 | -65 | N/A | -54 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 346 |
| Other Financing Activity | -48 | -32 | 0 | 0 | -433 |
| Financing Cash Flow | $134 | $150 | $72 | $N/A | $162 |
| Beginning Cash Position | 26 | 26 | 26 | N/A | 16 |
| End Cash Position | 15 | 21 | 6 | N/A | 24 |
| Net Cash Flow | $-11 | $-6 | $-21 | $N/A | $8 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146 | -156 | -93 | N/A | -154 |
| Free Cash Flow | -146 | -156 | -93 | 0 | -154 |